QT
VXRT

Quantamental Technologies’s Vaxart VXRT Stock Holding History

Quantamental Technologies’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,926
Closed -$222K – 509
2021
Q3 		$222K Buy
+27,926
New +$230K 0.15% 238
2019
Q1 		– Sell
-2,324
Closed -$4K – 1802
2018
Q4 		$4K Buy
+2,324
New +$6.92K ﹤0.01% 1246

Other funds holding VXRT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Quantamental Technologies's VXRT Position: Q4 2021 in Review

Quantamental Technologies sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 27,926 shares — an estimated $222K sold.

Quantamental Technologies first reported a position in VXRT in Q4 2018 and held it in 2 quarters. The position peaked at $222K in Q3 2021. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

  • Quantamental Technologies reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
  • Quantamental Technologies sold 27,926 Vaxart shares in Q4 2021, an estimated $222K.
  • Quantamental Technologies first reported a position in Vaxart in Q4 2018 and held it in 2 quarters.
  • Quantamental Technologies's Vaxart position peaked at $222K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on Quantamental Technologies's 13F filing for Q4 2021, filed 14 Feb 2022.